ストックスクリーナーアプリを入手
5.73
24.11%
-1.82
アフターアワーズ：
5.44
-0.29
-5.06%
前日終値:
$7.55
開ける：
$5.63
24時間の取引高:
1.35M
Relative Volume:
1.24
時価総額：
$4.75M
収益：
$275.60K
当期純損益:
$-8.33M
株価収益率:
-12.41
EPS:
-0.4619
ネットキャッシュフロー:
$-5.40M
1週間 パフォーマンス:
+30.52%
1か月 パフォーマンス:
-7.43%
6か月 パフォーマンス:
+1,528%
1年 パフォーマンス:
+523.23%
1日の値動き範囲:
$5.15
$5.95
1週間の範囲:
$4.10
$10.98
52週間の値動き範囲:
$0.2201
$10.98
Nexalin Technology Inc Stock (NXL) Company Profile
Compare NXL vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
5.73 | 3.64M | 275.60K | -8.33M | -5.40M | -0.4619 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc (NXL) 最新ニュース
Top Midday Gainers - Yahoo Finance
Trending Stocks Today | Nexalin Technology Surges 71.26% - Moomoo
Why Is Nexalin Technology Stock Gaining Thursday? - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Nexalin Technology shares surge on South America commercialization and manufacturing deal - Quiver Quantitative
Nexalin Technology Signs South America Distribution Agreement for Nexalin Sync Commercialization - Yahoo Finance
Nexalin Technology, Inc. (NXL) Stock Price, News, Quote & History - Yahoo! Finance Canada
NXL Stock Pops As Nexalin Technology Hires Global Commercial Advisor - StocksToTrade
Nexalin signs 10-year distribution deal for South America By Investing.com - Investing.com Canada
Nexalin Technology Signs Definitive Exclusive Distribution - GlobeNewswire
$Nexalin Technology (NXL.US)$ - Moomoo
Nexalin appoints Robert DiTota as senior strategic advisor By Investing.com - Investing.com South Africa
Nexalin Technology appoints DiTota as Senior Strategic Advisor - TipRanks
Nexalin appoints Robert DiTota as senior strategic advisor - Investing.com
Nexalin Technology Taps Neuromodulation Commercial - GlobeNewswire
A brain-stimulation device gets a 10-year deal across seven countries with more than 300 million residents - Stock Titan
Nexalin Technology Granted Conditional Nasdaq Listing Extension - TipRanks
Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NXL Should I Buy - Intellectia AI
Nexalin Technology Inc. (NASDAQ: NXL) Share Price, NXL Stock News, NXL Share Price & Updates - kalkine.com.au
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - ACCESS Newswire
Nexalin Technology (NXL) Slips 3.94% to $4.85 as Shares Drift Toward Lower SupportGolden Cross - dars.gov.et
Nexalin Technology (NXL) Declines 5.34% to $4.79, Pressuring Key Support LevelSupply Zone - siam.in
Nexalin Technology Announces Key Executive Leadership Departure - TipRanks
Nexalin Technology registers to sell 5.75M shares of common stock for holders - TipRanks
Multi-million-share resale could boost Nexalin (NASDAQ: NXL) share count - Stock Titan
Greenlight Ventures Discloses Investment at Nexalin Technology with 5.6% Stake - TradingView
Stock-for-deal investor steps in at Nexalin (NASDAQ: NXL) - Stock Titan
Nexalin Technology (NASDAQ: NXL) Announces Carolyn Shelton's Exit with $20,000 Bonus and Accelerated Stock Option Vesting - kalkinemedia.com
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to - Yahoo Finance
Carolyn Shelton exits Nexalin as Senior VP; separation terms include bonus and option vesting - TradingView
Nexalin Technology, Inc. Announces Resignation of Carolyn Shelton from Senior Vice President of Quality, Regulatory, and Clinical Affairs, Effective August 28, 2026 - marketscreener.com
Alumni Capital LP Holds 9.99% Stake in Nexalin Technology (NASDAQ: NXL), Disclosing 2.49 Million Shares - Kalkine Media
Nexalin Announces 1-for-30 Reverse Stock Split Approval - The Globe and Mail
Nexalin Technology approves 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Nexalin Technology Announces Reverse Stock Split - Yahoo Finance
Nexalin (NXL) Levels: Ends Higher by 0.45% at $0.33 in the Latest Reading - careplusvn.com
Nexalin Technology Raises Liquidity via Short-Term Note - TipRanks
Nexalin Technology Issues $1.17 Million OID Note for $1.0 Million Proceeds - TradingView
Nexalin Announces Capital Raise and Flexible Equity Facility - TipRanks
Nexalin Technology Raises $750,000 in Registered Direct Offering - minichart.com.sg
Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital - TradingView
Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingEPS Guidance Update - dars.gov.et
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - The Globe and Mail
Nexalin Technology earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa
Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexalin Technology earnings missed, revenue fell short of estimates - Investing.com
Nexalin Technology (NXL) Edges Higher at $0.36 as Neurostimulation Stock Holds Key SupportIceberg Order - dars.gov.et
Nexalin Technology, Inc. 2Q 2026: Revenue $12.16K, EPS ($0.11) — 10-Q Summary - TradingView
Nexalin Technology (NXL) flags going concern risk as losses mount and Nasdaq warns - Stock Titan
Nexalin Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
0.26%
0.38%
大文字化:
|
ボリューム (24 時間):